MET and pachyonychia congenita: Although at the present time there is no scientific explanation for why different signaling components predict survival in three distinct racial groups of PC patients, we speculate that the regulatory elements, including quantitative aspects of receptors, ligands, and interactions among effector molecules, controlling overall RANK- and c-Met-mediated downstream signaling could be different among interracial groups.